CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Ajanta Pharma USA Inc recalls Aripiprazole Tablets USP

Read the official FDA notice

Published
24 Jun 2026
Units affected
6,143 bottles
Agency
FDA
Country
United States

The hazard

Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03.

Brand / company
Ajanta Pharma USA Inc
Codes / lots
Lot: PA00805, expires: 01/31/2029
Distribution
U.S. Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 24 Jun 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.